Feldman EL, Callaghan BC, Pop-Busui R, Zochodne DW, Wright DE, Bennett DL, Bril V, Russell JW, Viswanathan V.
Nat Rev Dis Primers. 2019 Jun 13;5(1):42. doi: 10.1038/s41572-019-0097-9.
PMID:31197183
Diabetic neuropathy.
Feldman EL, Callaghan BC, Pop-Busui R, Zochodne DW, Wright DE, Bennett DL, Bril V, Russell JW, Viswanathan V.
Nat Rev Dis Primers. 2019 Jun 13;5(1):41. doi: 10.1038/s41572-019-0092-1.
PMID:31197153
Diabetic neuropathy: clinical manifestations and current treatments.
Callaghan BC, Cheng HT, Stables CL, Smith AL, Feldman EL.
Lancet Neurol. 2012 Jun;11(6):521-34. doi: 10.1016/S1474-4422(12)70065-0. Epub 2012 May 16.
PMID:22608666
Diabetic peripheral neuropathy essentials: a narrative review.
Chang MC, Yang S.
Ann Palliat Med. 2023 Mar;12(2):390-398. doi: 10.21037/apm-22-693. Epub 2023 Feb 8.
PMID:36786097
Metabolic syndrome and peripheral neuropathy.
Kazamel M, Stino AM, Smith AG.
Muscle Nerve. 2021 Mar;63(3):285-293. doi: 10.1002/mus.27086. Epub 2020 Oct 24.
PMID:33098165
Management of diabetic neuropathy.
Cernea S, Raz I.
Metabolism. 2021 Oct;123:154867. doi: 10.1016/j.metabol.2021.154867. Epub 2021 Aug 17.
PMID:34411554
Diabetic Neuropathies.
Elafros MA, Callaghan BC.
Continuum (Minneap Minn). 2023 Oct 1;29(5):1401-1417. doi: 10.1212/CON.0000000000001291.
PMID:37851036
High serum levels of CCL11/Eotaxin-1 are associated with diabetic sensorimotor polyneuropathy and peripheral nerve function but not with cardiac autonomic neuropathy in people with type 2 diabetes.
Aso Y, Iijima T, Jojima T, Saito M, Tanuma D, Kase M, Sakurai S, Tomaru T, Usui I.